Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Nov 16, 2021 $33.58 $34.08 $32.85 $33.57 735 623
Nov 15, 2021 $33.24 $34.19 $32.76 $33.87 1 041 078
Nov 12, 2021 $32.24 $32.78 $31.41 $32.71 1 031 192
Nov 11, 2021 $32.70 $32.93 $31.33 $31.94 1 207 553
Nov 10, 2021 $33.33 $34.35 $32.48 $32.59 1 072 157
Nov 09, 2021 $35.79 $35.95 $32.96 $33.46 1 543 832
Nov 08, 2021 $35.07 $35.88 $34.52 $35.40 1 358 606
Nov 05, 2021 $34.45 $37.77 $34.17 $35.35 2 953 118
Nov 04, 2021 $35.35 $40.69 $35.34 $39.37 2 154 502
Nov 03, 2021 $38.57 $40.41 $38.57 $40.26 1 162 790
Nov 02, 2021 $38.13 $39.22 $38.13 $39.10 1 038 107
Nov 01, 2021 $36.62 $39.13 $36.59 $38.94 1 606 565
Oct 29, 2021 $36.12 $38.00 $35.61 $36.52 1 808 283
Oct 28, 2021 $32.75 $36.48 $32.52 $36.33 1 968 930
Oct 27, 2021 $30.27 $32.88 $30.10 $32.78 1 232 780
Oct 26, 2021 $30.95 $31.27 $29.89 $30.00 1 171 917
Oct 25, 2021 $31.48 $32.10 $30.74 $30.86 973 605
Oct 22, 2021 $31.38 $31.65 $30.52 $31.57 1 044 435
Oct 21, 2021 $29.91 $31.51 $29.79 $31.36 996 786
Oct 20, 2021 $29.71 $30.43 $29.67 $29.79 795 973
Oct 19, 2021 $30.70 $31.53 $30.23 $30.31 626 950
Oct 18, 2021 $30.43 $31.49 $30.35 $30.71 1 029 419
Oct 15, 2021 $32.23 $32.23 $30.50 $30.52 819 751
Oct 14, 2021 $32.28 $32.88 $31.76 $31.93 671 143
Oct 13, 2021 $31.39 $32.48 $31.39 $32.00 728 329
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT